Tirzepatide
August 12, 2024
Semaglutide
$400.00 every 4 weeks
Description
Semaglutide is a GLP1 receptor agonist that was originally developed to treat diabetes by lowering blood glucose levels. It later received FDA approval as a weight loss medication for obese patients.
Reviews 0
Related products
-
Tirzepatide
$775.00 every 4 weeks
Reviews
There are no reviews yet.